Todor’s primary area of expertise is Pricing and Market Access, with additional focus on HEOR, RWE and artificial intelligence / machine learning. Todor has led numerous projects and engagements covering price-testing, market access assessment and landscaping, value story and value proposition development, as well as projects on various commercial aspects of product development. A particular interest and focus on strategic alignment and cross-functional integration is a result of Todor’s work for the Integrated Access Solutions Unit at Parexel, as well as for the Market Access Strategy unit at Icon. Todor has recent exposure to AI-based predictive and causal modelling, drug sequencing, synthetic control arm generation, leveraging advanced analytics methods such as Bayesian network analysis.
Todor has worked across a wide variety of therapeutic areas, including oncology, gastrointestinal diseases, inflammation and immunology – with extensive experience in the anti-TNF space, JAK-inhibitors and related therapies, CNS, cardiovascular disease, rare diseases, among others. He is an expert in qualitative primary research, with robust experience with payer panels, advisory boards, focus groups, KOL interviews, including innovative “dyad” interviews. Todor’s expertise covers a variety of quantitative analysis methods, including the AI / ML methods mentioned above.
Todor has authored peer-reviewed publications and presented at numerous conferences, industry meetings and events. His thought leadership cover topics ranging from innovative pricing agreements and contracting to new approaches in value proposition and value story development. Todor completed a PhD in Political Economy at the University of Pennsylvania and resides in the greater NYC / Philadelphia area.